Integra Lifesciences Holdings (IART) Interest & Investment Income (2009 - 2026)

Integra Lifesciences Holdings has disclosed Interest & Investment Income across 18 years of filings, most recently posting $4.3 million for Q2 2026.

• In Q2 2026, Interest & Investment Income fell 9.41% year-over-year to $4.3 million; the TTM figure through Jun 2026 stood at $17.7 million (down 7.1% YoY), while the FY2025 annual figure was $18.5 million, down 7.81% from the prior year.
• Interest & Investment Income came in at $4.3 million for Q2 2026 at Integra Lifesciences Holdings, up from $4.1 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $5.3 million in Q4 2022 to a low of $1.4 million in Q1 2022.
• Average Interest & Investment Income over 5 years is $4.2 million, with a median of $4.5 million recorded in 2023.
• The largest YoY upside for Interest & Investment Income was 269.08% in 2022 against a maximum downside of 21.22% in 2022.
• Over 5 years, Interest & Investment Income stood at $5.3 million in 2022, then slipped by 14.35% to $4.5 million in 2023, then grew by 7.56% to $4.9 million in 2024, then decreased by 10.85% to $4.4 million in 2025, then retreated by 2.18% to $4.3 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $4.3 million in Q2 2026, $4.1 million in Q1 2026, and $4.4 million in Q4 2025.